A critical point that hasn’t been fully explored is patient adherence. Tablet forms can offer discreet, odorless, and convenient dosing, which might improve compliance in settings where mixing powders or carrying liquid supplements is impractical. However, for individuals with swallowing difficulties or those requiring higher protein loads, tablets could present unique barriers. Anecdotally, there’s also some variability in gastrointestinal tolerance, which seems formulation-dependent. More real-world data directly comparing these practical aspects would be quite valuable for guiding patient-specific recommendations.